• 26
  • 6
  • 收藏

Pardes to go public, says COVID-19 antiviral pill does not need booster

Reuters2021-12-21

(Reuters) - Pardes Biosciences on Tuesday said early human testing shows that its experimental COVID-19 antiviral pill works as a standalone treatment and announced plans to go public by merging with ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论6

  • RT126
    ·2021-12-21
    Vaccines is good
    回复
    举报
  • NPC69
    ·2021-12-21
    K
    回复
    举报
    收起
    • vxf
      stay invested
      2021-12-21
      回复
      举报
  • LY1970
    ·2021-12-21
    Hi
    回复
    举报
  • Kiattt
    ·2021-12-21
    Like
    回复
    举报
    收起
  • edwinong
    ·2021-12-21
    Like
    回复
    举报
    收起
    • Kiattt
      K
      2021-12-21
      回复
      举报
  • Ccl2
    ·2021-12-21
    Like
    回复
    举报
    收起
    • LY1970
      Ji
      2021-12-21
      回复
      举报
    • Ccl2
      Like
      2021-12-21
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24